Genomics Medicine Ireland has raised €36m ($40m) in a funding round and will create 150 jobs. The life sciences start-up, which develops treatments for Alzheimer's and multiple sclerosis, will use the investment to set-up a genomics R&D programme in Ireland and to improve understanding of factors involved in disease. Series A funding round investors include the Ireland Strategic Investment Fund, Polaris Partners, ARCH Venture Partners, and GV (previously Google Ventures).
Genomics Medicine Ireland has raised €36m ($40m) in a funding round and will create 150 jobs. The life sciences start-up, which develops treatments for Alzheimer's and multiple sclerosis, will use the investment to set-up a genomics R&D programme in Dublin and to improve understanding of factors involved in disease. Series A funding round investors include the Ireland Strategic Investment Fund, Polaris Partners, ARCH Venture Partners, and GV (previously Google Ventures).